Cutaneous Melanoma
📧 Sign up to get email alerts when something new happens for Cutaneous Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma [Phase 2]
Phase 2 trial evaluating prostaglandin inhibition combined with immune checkpoint blockade in melanoma; completed with results posted in 202…
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma [Phase 3]
A Phase 3 trial comparing MEK162 (binimetinib) to dacarbazine in NRAS-mutant unresectable or metastatic melanoma has completed; results were…
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer [Phase 1, Phase 2]
Phase 1/2 trial update of uprosertib combined with dabrafenib and trametinib in patients with stage IIIC-IV melanoma (cutaneous/metastatic/u…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV Melanoma [Phase 2]
Phase 2 clinical trial update evaluating multiple targeted therapies (capmatinib, ceritinib, regorafenib, or entrectinib) in patients with B…
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating nab-paclitaxel with bevacizumab or ipilimumab as first-line therapy in patients with unresectable stage IV melanoma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Confirmatory Trial in the Evaluation of Ca Electroporation for the Treatment of Cutaneous Metastases [NA]
A completed clinical trial evaluating calcium electroporation for treating cutaneous metastases in cutaneous melanoma; results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-18Clinical Trial Update: Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma [Phase 2]
NCI-sponsored Phase 2 trial evaluating ibrutinib in patients with refractory metastatic cutaneous melanoma; results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-05-10Clinical Trial Update: Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating aldesleukin with or without ziv-aflibercept in patients with unresectable stage III-IV metastatic melanoma.
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma [Phase 2]
A Phase 2 clinical trial evaluating Oncoxin-Viusid for cutaneous melanoma has completed, with the study status reported as completed.
-
CLINICAL_TRIALS trial_result · 2018-02-09Clinical Trial Update: Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma [Phase 2]
Phase II study investigating KW2871 with high-dose Interferon-α2b in metastatic/cutaneous melanoma completed with posted results in 2018.
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma [Phase 2]
Phase 2 study evaluating epacadostat with a vaccine therapy in patients with stage III-IV melanoma has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: Vaccine Therapy in Treating Patients With Advanced Melanoma [Phase 1]
Phase 1 clinical trial of a melanoma vaccine therapy has completed. The study evaluated safety in patients with advanced melanoma, including…
-
CLINICAL_TRIALS trial_result · 2016-08-10Clinical Trial Update: Determine Toxicity and Antibody Responses With a KLH Conjugated Bivalent Vaccine Containing GD2 Lactone, GD3 Lactone With Immunological Adjuvant QS-DG or OPT-821 in Patients With Disease Free AJCC Stage III or IV Cutaneous Melanoma [NA]
Completed study evaluating toxicity and antibody responses of a KLH-conjugated bivalent GD2/GD3 vaccine with QS-DG or OPT-821 adjuvants in d…
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: Dinaciclib in Treating Patients With Stage IV Melanoma [Phase 2]
A Phase 2 trial of dinaciclib in patients with Stage IV melanoma has results posted.
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma [Phase 1]
Phase 1 trial evaluating ADI-PEG 20 plus cisplatin in metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Japan PhI/II of GSK2118436 and GSK1120212 Combination in Subjects With BRAF V600E/K Mutation Positive Advanced Solid Tumors (Phase I Part) or Cutaneous Melanoma (Phase II Part) [Phase 2]
Phase I/II trial update from Japan evaluating the dabrafenib and trametinib combination in patients with BRAF V600 mutation-positive advance…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery [Phase 1]
A Phase 1 trial evaluated a monoclonal antibody and vaccine therapy in patients with stage III or stage IV melanoma that had been surgically…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma [Phase 1]
This Phase 1 trial evaluates a vaccine therapy in patients with stage III or stage IV melanoma, including intraocular melanoma and cutaneous…
-
CLINICAL_TRIALS trial_result · 2014-02-21Clinical Trial Update: Dendritic Cell Vaccination During Lymphoid Reconstruction [Phase 1]
Phase 1 trial of dendritic cell vaccination during lymphoid reconstruction for uveal melanoma and cutaneous melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
Expanded-access study of melphalan with the Delcath CS-PHP system for liver metastases from ocular or cutaneous melanoma is no longer availa…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma [Phase 1, Phase 2]
A completed phase 1/2 trial evaluating temozolomide and thalidomide in patients with stage III or stage IV melanoma, including intraocular a…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma [Phase 2]
A Phase 2 trial evaluating temozolomide plus interferon alfa in patients with stage III or stage IV melanoma, including intraocular and cuta…
-
CLINICAL_TRIALS trial_result · 2013-04-08Clinical Trial Update: PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating pegylated interferon alfa-2b in combination with thalidomide for patients with recurrent or metastatic melanoma. Th…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma [Phase 2]
A Phase 2 trial evaluated a combination of temozolomide, thalidomide, and lomustine in patients with unresectable stage III or IV melanoma, …
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Drosophila-generated CTL [Phase 2]
Phase 2 trial update from the National Cancer Institute on Drosophila-generated cytotoxic T lymphocytes for metastatic cutaneous melanoma. T…